Elmiron (sodium pentosan polysulphate)
Executive Summary
Medical Market Specialties acquires exclusive U.S. marketing rights to the orphan drug from Pharmacia. MMS said it acquired rights to Elmiron, for use in the treatment of interstitial cystitis, after Rep. Waxman (D-Calif.) requested Pharmacia's parent, Pharmacia AB, to make the drug available in the U.S.